Predictors of future exacerbation risk in patients with asthma

References

• Global Initiative for Asthma 2016:updated from global strategy for asthma management and prevention. Workshop Report 2016. Available from: www.ginasthma.com.
   Google Scholar
• James AL, Knuiman MW, Divitini ML, et al. Changes in the prevalence of asthma in adults since 1966: the Busselton health study. Eur Respir J. 2010;35:273–278.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–178.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30:452–456.
   PubMed Web of Science ®Google Scholar
• Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med. 2006;100:434–450.
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Miller DP, et al. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481–489.
   PubMed Web of Science ®Google Scholar
• Ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26:812–818.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res. 2007;9:53–56.
   PubMed Web of Science ®Google Scholar
• Osborne ML, Pedula KL, O’Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the profile of asthma risk study: a prospective health maintenance organization-based study. Chest. 2007;132:1151–1161.
   PubMed Web of Science ®Google Scholar
• Fu JJ, McDonald VM, Baines KJ, et al. Airway IL-1beta and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest. 2015;148:618–629.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. GINA workshop report, global strategy for asthma management and prevention. 2013 Revised 2013. Available from: http://www.ginasthma.org
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107–1136.
   PubMed Web of Science ®Google Scholar
• Popa V. ATS guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med. 2001;163:292–293.
   PubMed Web of Science ®Google Scholar
• Tseliou E, Bakakos P, Kostikas K, et al. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma. Allergy. 2012;67:396–402.
   PubMed Web of Science ®Google Scholar
• Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002;37:19s–23s.
   Google Scholar
• Kips JC, Fahy JV, Hargreave FE, et al. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl. 1998;26:9S–12S.
   PubMedGoogle Scholar
• Grootendorst DC, van den Bos JW, Romeijn JJ, et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J. 1999;13:647–653.
   PubMed Web of Science ®Google Scholar
• ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930.
   PubMed Web of Science ®Google Scholar
• Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res. 2006;7:67.
   PubMed Web of Science ®Google Scholar
• Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the “gold standard” technique. Chest. 2007;131:410–414.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99.
   PubMed Web of Science ®Google Scholar
• Aaron SD, Fergusson D, Marks GB, et al. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax. 2008;63:122–128.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Plaza V. Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Chest. 2007;132:1513–1519.
   PubMed Web of Science ®Google Scholar
• Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP) : design, rationale, and methods. Control Clin Trials. 1999;20:91–120.
   PubMedGoogle Scholar
• Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone study group. Ann Intern Med. 1999;130:487–495.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337:1405–1411.
   PubMed Web of Science ®Google Scholar
• Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med. 2000;161:527–534.
   PubMed Web of Science ®Google Scholar
• Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997;337:1659–1665.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107:61–67.
   PubMed Web of Science ®Google Scholar
• Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194–1200.
   PubMed Web of Science ®Google Scholar
• Aburuz S, McElnay J, Gamble J, et al. Relationship between lung function and asthma symptoms in patients with difficult to control asthma. J Asthma. 2005;42:859–864.
   PubMed Web of Science ®Google Scholar
• Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol. 2007;120:1233–1244. quiz 1245-1236.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006;174:633–638.
   PubMed Web of Science ®Google Scholar
• Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med. 2006;174:112–119.
   PubMed Web of Science ®Google Scholar
• Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008;121:1087–1093. quiz 1094-1085.
   PubMed Web of Science ®Google Scholar
• Louis R, Lau LC, Bron AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161:9–16.
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46:1308–1321.
   PubMed Web of Science ®Google Scholar
• Price D, Wilson AM, Chisholm A, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12.
   PubMed Web of Science ®Google Scholar
• Al-Samri MT, Benedetti A, Prefontaine D, et al. Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples. J Allergy Clin Immunol. 2010;125(1161–1163):e1164.
   Google Scholar
• Michils A, Louis R, Peche R, et al. Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J. 2009;33:1295–1301.
   PubMed Web of Science ®Google Scholar
• Michils A, Peche R, Baldassarre S, et al. Comparisons between portable and chemoluminescence exhaled nitric oxide measurements. Eur Respir J. 2008;32:243–244.
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Minas M, Tanou K, et al. Exhaled NO may predict loss of asthma control: the effect of concomitant allergic rhinitis. Eur Respir J. 2009;34:1006–1007.
   PubMed Web of Science ®Google Scholar
• Malerba M, Radaeli A, Olivini A, et al. The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study. Curr Pharm Des. 2015;21:4752–4762.
   PubMed Web of Science ®Google Scholar
• Malerba M, Ragnoli B, Radaeli A, et al. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest. 2008;134:733–739.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360(9347):1715–1721.
   PubMed Web of Science ®Google Scholar